CYP4F35P: A Pseudogene Encoding A Cytochrome P450 Enzyme (G284233)

Target Name: CYP4F35P

NCBI ID: G284233

CYP4F35P

Other Name(s): cytochrome P450 family 4 subfamily F member 35, pseudogene | Cytochrome P450 family 4 subfamily F member 35, pseudogene

CYP4F35P: A Pseudogene Encoding A Cytochrome P450 Enzyme

CYP4F35P, also known as cytochrome P450 family 4 subfamily F member 35, is a pseudogene that is expressed in various tissues and organs in the body. It is a member of the cytochrome P450 (CYP) gene family, which encodes for a group of enzymes that are involved in drug metabolism and other physiological processes.

The CYP4F35P gene was first identified in the late 1990s using DNA sequencing techniques. It is located on chromosome 19 at position 35 and has a single open reading frame with a protein coding region of 1,148 amino acids. The protein produced by this gene has a calculated molecular weight of 17,411 Da and a calculated pI of 4.94.

The CYP4F35P gene is a member of the CYP450 family, which includes 33 pseudogenes that are encoded for proteins involved in drug metabolism, including enzymes that are involved in the metabolism of both drugs and endogenous compounds. The CYP450 family is one of the most well-studied gene families in the CYP gene cluster, with many potential drug targets identified and described in the literature.

One of the key functions of the CYP450 family is its role in drug metabolism. These enzymes are involved in the metabolism of a wide variety of drugs, including statins, antidepressants, and antipsychotics. They are also involved in the production of various metabolites, which can either enhance or decrease the efficacy of these drugs.

In addition to its role in drug metabolism, the CYP450 family is also involved in the production of other compounds that are important for various physiological processes in the body. These include sex hormones, including estrogen and testosterone, as well as various neurotransmitters, such as dopamine and serotonin.

The CYP450 family is also involved in the regulation of various physiological processes in the body, including inflammation, stress response, and cellular signaling. For example, the CYP450 family is involved in the production of pro-inflammatory cytokines, such as TNF-伪, which play a key role in the regulation of inflammation and immune responses.

The CYP450 family is also involved in the regulation of cellular signaling, including the production of various signaling molecules that are involved in cell signaling pathways. For example, the CYP450 family is involved in the production of the neurotransmitter GABA, which is involved in inhibitory signaling pathways.

The CYP450 family is also involved in the regulation of various physiological processes in the body, including aging and DNA damage. For example, the CYP450 family is involved in the production of various metabolites that are involved in the regulation of cellular aging, as well as in the repair of DNA damage.

In conclusion, CYP4F35P is a pseudogene that is expressed in various tissues and organs in the body. It is a member of the CYP450 family and is involved in the production of various compounds that are important for various physiological processes in the body. The CYP450 family is also involved in the regulation of drug metabolism, stress response, cellular signaling, and other physiological processes in the body. As a result, CYP4F35P may be a drug target or biomarker for various diseases.

Protein Name: Cytochrome P450 Family 4 Subfamily F Member 35, Pseudogene

The "CYP4F35P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP4F35P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets